Similarly, in HD patients, Hogas et al. showed that a level of galectin-3 > 23.73 ng/mL was an independent predictor of mortality (HR: 2.60; 95% CI[1.09, 6.18])23, and a more long-term data also showed similar results11. This evidence concerns the gene LGALS3 and Huntington disease.